XML 68 R60.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Capital - Disclosure of number and weighted average exercise prices of other equity instruments (Details)
Jun. 30, 2024
shares
€ / shares
Jun. 10, 2024
share
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) | share   106,844
Warrants    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 12,914,414  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 3,239,985  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 3,340,434  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 6,333,995  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 7,084,922  
BSAAR 2011    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 650,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 25,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 625,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 2.04  
BSAAR 2012    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 146,050  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 12,250  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 133,800  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 2.04  
BSAAR 2015    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 1,050,382  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 2,720  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 1,940  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 1,045,722  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 1,045,722  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 7.20  
AGAP Management 2016-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 2,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 550  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 250  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 1,200  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 156,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Employees 2016-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 2,486  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 251  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 172  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 2,063  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 268,190  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Management 2016-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 50,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 50,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Management 2016-2    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 3,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 3,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 333,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Management 2016-2    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 250,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 250,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Employees 2017-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 5,725  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 5,725  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Management 2017-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 2,400  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 2,400  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Employees 2017    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 114,500  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 4,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 110,500  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Bonus 2018-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 67,028  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 469  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 66,559  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Perf Employees 2018-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 327,500  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 224,375  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 103,125  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Perf Management 2018-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 260,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 150,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 110,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Employees 2018    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 90,650  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 5,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 85,650  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA New Members 2017-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 25,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 25,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Bonus 2019-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 57,376  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 57,376  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Bonus 2020-1 & 2    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 79,861  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 17,885  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 61,976  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Employees 2020-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 766,650  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 681,420  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 85,230  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Management 2020-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 710,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 580,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 130,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Bonus 2021-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 125,748  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 125,748  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Employees 2021-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 1,066,600  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 290,800  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 775,800  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 775,800  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP Management 2021-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 610,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 130,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 480,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 480,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA "Plan Epargne Entreprise" 2022    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 138,960  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 138,960  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Bonus 2022-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 128,061  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 128,061  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Perf Employees 2022-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 1,371,500  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 275,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 1,096,500  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 1,096,500  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Perf Management 2022-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 550,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 550,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 550,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA "Plan Epargne Entreprise" 2023    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 163,293  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 163,293  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA New members 2023-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 25,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 25,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 25,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Perf Employees 2023-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 1,403,500  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 66,250  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 1,337,250  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 1,337,250  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA Perf Management 2023-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 750,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 750,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 750,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA New members 2024-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 25,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 25,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 25,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGA "Plan Epargne Entreprise" 2024    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 68,744  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 68,744  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
Stock Options 2020-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 102,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 102,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP 2019 Employees 2019    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 546,700  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 375,150  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 171,550  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
AGAP 2019 Management 2019    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 355,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 207,500  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 147,500  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 0  
BSA 2011-2    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 225,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 25,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 200,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 1.77  
BSA 2013    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 237,500  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 12,500  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 225,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 0  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 2.36  
BSA 2014    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 150,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 75,000  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 75,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 75,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 8.65  
BSA 2015-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 70,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 70,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 70,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 9.59  
BSA 2015-2    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 14,200  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 14,200  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 14,200  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 14.05  
BSA 2017    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 37,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 0  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 37,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 37,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 11.00  
BSA 2022-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 40,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 31,740  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 8,260  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 8,260  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 2.31  
BSA 2023-1    
Disclosure of terms and conditions of share-based payment arrangement [Line Items]    
Number of free shares granted (in shares) 50,000  
Number of other equity instruments forfeited in share-based payment arrangement (in shares) 12,000  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 0  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) 38,000  
Number of other equity instruments exercisable in share-based payment arrangement (in shares) 38,000  
Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares € 2.26